{"id":"NCT00405964","sponsor":"Organon and Co","briefTitle":"Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)","officialTitle":"Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Meet the Criteria for Persistent Allergic Rhinitis (PER)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-09","primaryCompletion":"2008-04","completion":"2008-04","firstPosted":"2006-12-04","resultsPosted":"2010-11-19","lastUpdate":"2024-05-20"},"enrollment":716,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"5-mg Desloratadine","otherNames":["SCH 34117, Aerius"]},{"type":"DRUG","name":"Placebo tablet","otherNames":[]}],"arms":[{"label":"5-mg Desloratadine tablet","type":"EXPERIMENTAL"},{"label":"Placebo tablet","type":"PLACEBO_COMPARATOR"}],"summary":"This study will investigate the effectiveness of desloratadine in treating subjects with allergic rhinitis who meet the criteria for persistent allergic rhinitis (PER)","primaryOutcome":{"measure":"Change From Baseline in Participant's AM/PM PRIOR Total 5 Symptom Score (T5SS) Over Days 1 to 29 of Treatment","timeFrame":"Baseline and Days 1-29","effectByArm":[{"arm":"5-mg Desloratadine Tablet","deltaMin":9.63,"sd":0.13},{"arm":"Placebo Tablet","deltaMin":9.55,"sd":0.12}],"pValues":[{"comp":"OG000 vs OG001","p":"<.001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":17},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20559006","23676577"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":360},"commonTop":["Headache","Nasopharyngitis"]}}